| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |